|
Delayed
OTC Markets
11:14:35 2021-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 4.510 USD | -5.65% |
|
-2.45% | - |
| 09-11 | Cosmos Health Unit Enters 5-Year Contract Manufacturing Deal With Viofar Over Cardiovascular Medicine | MT |
| 09-03 | Cosmos Health Inc. Reaffirms Earnings Guidance for the Year 2026, 2027 and 2029 | CI |
Company Valuation: Cosmos Holdings Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 48.22 | 18.78 | 14.06 | 17.39 | 38.25 | - |
| Change | - | -61.06% | -25.13% | 23.7% | 119.96% | - |
| Enterprise Value (EV) | 48.22 | 18.78 | 14.06 | 17.39 | 38.25 | 38.25 |
| Change | - | -61.06% | -25.13% | 23.7% | 119.96% | 0% |
| P/E | -0.14x | -0.66x | -0.57x | -0.79x | -1.81x | 5.43x |
| PBR | - | - | - | - | - | - |
| PEG | - | 0x | 0x | 0x | 0x | -0x |
| Capitalization / Revenue | - | 0.35x | - | 0.27x | 0.47x | 0.35x |
| EV / Revenue | - | 0x | - | 0x | 0.47x | 0.35x |
| EV / EBITDA | - | - | - | - | - | - |
| EV / EBIT | - | - | - | - | - | - |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -33.16 | -2.15 | -1.17 | -0.63 | -0.21 | 0.07 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 53.38 | - | 65.27 | 80.8 | 110.8 |
| EBITDA | - | -21.24 | - | - | - | - |
| EBIT | - | -21.83 | - | - | - | - |
| Net income | -13.83 | -25.78 | -22.38 | -19.14 | - | - |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 4.5600 | 1.4100 | 0.6690 | 0.4980 | 0.3801 | 0.3801 |
| Nbr of stocks (in thousands) | 10,574 | 13,318 | 21,014 | 34,920 | 100,634 | - |
| Announcement Date | 4/12/23 | 8/5/24 | 4/15/25 | 4/15/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.28x | 0.24x | 14.01x | 0.42% | 101B | |
| 21.76x | 0.2x | 12.2x | 0.94% | 51.55B | |
| 34.24x | 2.57x | 23.17x | 1.76% | 20.81B | |
| 10.56x | 0.19x | 4.41x | 2.86% | 7.93B | |
| 12.66x | 0.9x | 7.43x | 3.14% | 6.8B | |
| 9.61x | 1.81x | 5.72x | 3.56% | 6.52B | |
| 5.33x | 0.08x | 2.35x | 5.56% | 5.93B | |
| 24.79x | 1.13x | 14.23x | 3.09% | 4.95B | |
| 13.86x | - | - | 2.39% | 4.02B | |
| Average | 17.23x | 0.89x | 10.44x | 2.64% | 23.32B | |
| Weighted average by Cap. | 21.61x | 0.56x | 13.30x | 1.2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- COSM Stock
- COSM Stock
- Valuation Cosmos Holdings Inc.
Select your edition
All financial news and data tailored to specific country editions
